Health Care/Hospital

Medical Tourism Conference Moves to Abu Dhabi with Highest Quality of Participants in 12 Years

WEST PALM BEACH, Florida, Oct. 2, 2019 /PRNewswire/ -- Hosted buyers, expert speakers, Ministers of Health, and hundreds of other healthcare executives will travel toAbu Dhabi next month as delegates to the 12th World Medical Tourism & Global Healthcare Congress (WMTC). The Congress, which hopes ...

2019-10-02 01:45 1980

Clarivate Analytics introduces next-generation pre-clinical drug research platform with Cortellis Drug Discovery Intelligence

Updated solution enables enhanced analytics and greater utility of biology, chemistry and pharmacology data—within a single application LONDON and PHILADELPHIA, Oct. 2, 2019 /PRNewswire/ -- Clarivate Analytics plc (NYSE:CCC; CCC.WS), a global leader in providing trusted insights and analytics to...

2019-10-02 01:39 8265

Startling Healthcare Developments Revealed at Successful IDTechEx Healthcare Sensor Innovations 2019 Conference

CAMBRIDGE, England, Oct. 2, 2019 /PRNewswire/ -- Healthcare Sensor Innovations , a brand-new event organized by market intelligence and events companyIDTechEx , opened to a packed audience in Cambridge, Un...

2019-10-02 00:36 1616

CapsCanada Expands Growth to New State-of-the-Art Facility

DANIA BEACH, Florida, Oct. 1, 2019 /PRNewswire/ -- CapsCanada®, the leading innovator of vegetarian K-CAPS®, accelerates growth by relocating their headquarters to a new state-of-the-art facility strategically located in Dania Beach,Florida, with close proximity to two major interstate highways, ...

2019-10-01 19:00 1244

Asia Derma returns to Singapore for second edition

SINGAPORE, Oct. 1, 2019 /PRNewswire/ -- After a successful first run in 2018, Asia Derma, the Asia Pacific Dermatology and Aesthetic Conference & Exhibition returns toSingapore for a second edition. The leading industry event for skin professionals in the region will take place at the Suntec Sing...

2019-10-01 15:28 1099

AGC Biologics Appoints New Site Head/General Manager of Copenhagen, Denmark Operations

Jeffrey D. Mowery Named Site Head/General Manager BOTHELL, Washington, Oct. 1, 2019 /PRNewswire/ -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the appointment ofJeffery D. Mowery as Site Head/General Manager of theCopenhagen,...

2019-10-01 07:00 2311

Amaris B. Clinic, a body management and sculpting clinic, is expanding its services into fitness and injury rehabilitation using vacuum compression therapy in a vacuum pod

SINGAPORE, Sept. 30, 2019 /PRNewswire/ -- Amaris B. Clinic, a provider of Medical Aesthetic services inSingapore, has recently announced its service expansion into the domain of fitness - streamlining its focus toAesthetics, Sculpting and Fitness. An increased awareness among people in regards t...

2019-09-30 20:56 2384

CKHH Aims to Deconsolidate Chi-Med and to Hold as a Strategic Investment for the Long Term

NEW YORK and LONDON, Sept. 30, 2019 /PRNewswire/ -- CK Hutchison Holdings Limited ("CKHH") announces its intention to sell approximately 1.3% of the total outstanding share capital in Hutchison China MediTech Limited ("Chi-Med") through an underwritten public offering, which would reduce its stak...

2019-09-30 19:01 1325

ESMO 2019: CStone presents pooled safety data from the Phase 1b trial of CS1001, demonstrating promising overall safety and tolerability

SUZHOU, China, Sept. 30, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) released pooled safety data from the Phase Ib (GEMSTONE-101) study of the Company's anti-PD-L1 antibody CS1001 in a poster presentation at the European Society of Medical Oncology 2019 Con...

2019-09-30 18:29 2714

Ascletis Announces Departure of Chief Financial Officer

HANGZHOU and SHAOXING, China, Sept. 30, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces that Dr.Lindi Tan, Chi...

2019-09-30 16:30 2870

First Digital Health Osteoarthritis Wearable Glove System Starts Pre-launch Pilot Trial Series & Medical Tests

MADRID, Sept. 30, 2019 /PRNewswire/ -- QUANTIC NANOTECH , a product division of SpanishDEMAC S.A. group who presented the first home wearable osteoarthritis treatment glove system "QNANO GLOVE " during the last CES 2019 Edition in Las Vegas, announ...

2019-09-30 16:04 2109

Interleukin 11 Identified as New Therapeutic Target for Idiopathic Pulmonary Fibrosis

* Idiopathic pulmonary fibrosis (IPF) is a severe and fatal disease that causes lung damage and scarring * Blocking a protein called interleukin-11 (IL11), which is abnormally high in the lungs of patients with IPF, can reverse lung fibrosis and scarring in preclinical studies * Enleofen Bi...

2019-09-30 15:00 1072

New Major Order From China

STOCKHOLM, Sept. 30, 2019 /PRNewswire/ -- Bactiguard has received a new order from Well Lead Medical (Well Lead) inChina. The order will be delivered promptly and generate revenues in the third quarter of approximatelySEK 4,8 million. "The order we have just received from Well Lead is the first ...

2019-09-30 11:45 3791

Data From Ascensia Diabetes Care Shows High Accuracy of the CONTOUR®PLUS and CONTOUR®PLUS ONE BGMS in Low Blood Glucose Range and Potential Benefits From Using the CONTOUR®PLUS ONE BGMS With the Health2Sync App

HONG KONG, Sept. 30, 2019 /PRNewswire/ -- At the 21st Diabetes and Cardiovascular Risk Factors – East Meets West Symposium, Ascensia Diabetes Care has presented data from two studies, one analyzing the accuracy of blood glucose monitoring systems (BGMSs) in the low blood glucose range (LBGR) ...

2019-09-30 09:00 2564

Osteopore debuts on ASX, taking its unique 3D bone implant printing global

PERTH, Australia, Sept. 30, 2019 /PRNewswire/ -- Osteopore International, a Singaporean bone regeneration technology provider has debuted on the Australian Securities Exchange with an AUS$5.25million IPO. With a strong demand, Osteopore shares opened at63 cents and rose to as high as 80 cents on ...

2019-09-30 09:00 3699

Phase 3 PRIMA trial of Zejula® (niraparib) is the first study to show a PARP inhibitor significantly improves PFS, regardless of biomarker status, when given as monotherapy in women with first-line platinum responsive advanced ovarian cancer

* The PRIMA study, presented in a Presidential Symposium at the 2019 European Society for Medical Oncology congress and simultaneously published inThe New England Journal of Medicine,demonstrates that niraparib treatment resulted in a 38% reduction in the risk of disease progression or death in...

2019-09-29 12:13 8765
1 ... 562563564565566